TD Asset Management Inc Acquires 569,305 Shares of Cencora, Inc. $COR

TD Asset Management Inc raised its position in Cencora, Inc. (NYSE:COR) by 178.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 887,846 shares of the company’s stock after buying an additional 569,305 shares during the quarter. TD Asset Management Inc’s holdings in Cencora were worth $299,870,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Lido Advisors LLC increased its holdings in Cencora by 2.0% in the 4th quarter. Lido Advisors LLC now owns 8,956 shares of the company’s stock valued at $2,880,000 after buying an additional 178 shares during the period. WCG Wealth Advisors LLC bought a new position in Cencora in the 4th quarter valued at about $8,449,000. CIBC Asset Management Inc increased its holdings in Cencora by 28.9% in the 4th quarter. CIBC Asset Management Inc now owns 85,355 shares of the company’s stock valued at $28,816,000 after buying an additional 19,154 shares during the period. Marble Wealth LLC bought a new stake in Cencora during the fourth quarter worth $419,000. Finally, Bridges Investment Management Inc. lifted its stake in Cencora by 35.6% during the fourth quarter. Bridges Investment Management Inc. now owns 2,357 shares of the company’s stock worth $796,000 after purchasing an additional 619 shares during the last quarter. 97.52% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on COR shares. Robert W. Baird cut their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. UBS Group boosted their price target on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Evercore set a $360.00 price target on Cencora in a report on Wednesday, April 8th. Weiss Ratings cut Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 22nd. Finally, Barclays lifted their target price on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $380.25.

Cencora Price Performance

Shares of NYSE:COR opened at $264.40 on Thursday. The firm has a 50 day simple moving average of $294.84 and a 200 day simple moving average of $331.59. The company has a market cap of $51.44 billion, a price-to-earnings ratio of 20.28, a PEG ratio of 1.22 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the company posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Research analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.

Cencora declared that its Board of Directors has initiated a stock repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.